Individualized dosing for high-dose targeted radiation of hematopoietic cells with Iomab-B (I131-apamistamab) prior to HCT in relapsed/refractory acute myeloid leukemia (R/R AML): Safety and efficacy results from the pivotal phase 3 SIERRA trial Meeting Abstract

  


Authors: Pandit-Taskar, N.; Natwa, M.; Chen, M. K.; Wagner, R.; Yap, W.; Griffeth, L.; Wiseman, G.; Mhlanga, J.; Wahl, R.; Avril, N.; Lamonica, D.; Vesselle, H.; Chasen, B.; Johnson, C.; Hansen, N.; Leung, E.; Osborne, J.; Peterson, J.; Menda, Y.; Franceschi, D.; Desai, A.; Brodin, P.; Haeuber, E.; Nahar, A.; Passalaqua, S.
Abstract Title: Individualized dosing for high-dose targeted radiation of hematopoietic cells with Iomab-B (I131-apamistamab) prior to HCT in relapsed/refractory acute myeloid leukemia (R/R AML): Safety and efficacy results from the pivotal phase 3 SIERRA trial
Meeting Title: 2023 SNMMI Annual Meeting
Journal Title: Journal of Nuclear Medicine
Volume: 64
Issue: Suppl. 1
Meeting Dates: 2023 Jun 24-27
Meeting Location: Chicago, IL
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2023-06-01
Language: English
ACCESSION: WOS:001109210201151
PROVIDER: wos
Notes: Meeting Abstract: P685 -- Source: Wos